25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

509079 (Gufic) Stock Analysis
Buy, Hold or Sell?

Let's analyze Gufic together

I guess you are interested in Gufic Biosciences Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Gufic’s Financial Insights
  • 📈 Technical Analysis (TA) – Gufic’s Price Targets

I'm going to help you getting a better view of Gufic Biosciences Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Gufic Biosciences Limited

I send you an email if I find something interesting about Gufic Biosciences Limited.

1. Quick Overview

1.1. Quick analysis of Gufic (30 sec.)










1.2. What can you expect buying and holding a share of Gufic? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR27.76
Expected worth in 1 year
INR67.24
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR39.86
Return On Investment
10.6%

For what price can you sell your share?

Current Price per Share
INR377.75
Expected price per share
INR285.00 - INR459.55
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Gufic (5 min.)




Live pricePrice per Share (EOD)
INR377.75
Intrinsic Value Per Share
INR33.29 - INR73.19
Total Value Per Share
INR61.05 - INR100.95

2.2. Growth of Gufic (5 min.)




Is Gufic growing?

Current yearPrevious yearGrowGrow %
How rich?$31.7m$20.4m$11.2m35.6%

How much money is Gufic making?

Current yearPrevious yearGrowGrow %
Making money$11.3m$5.2m$6m53.8%
Net Profit Margin12.3%9.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Gufic (5 min.)




2.4. Comparing to competitors in the Drugs - Generic industry (5 min.)




  Industry Rankings (Drugs - Generic)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Gufic?

Welcome investor! Gufic's management wants to use your money to grow the business. In return you get a share of Gufic.

First you should know what it really means to hold a share of Gufic. And how you can make/lose money.

Speculation

The Price per Share of Gufic is INR377.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gufic.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gufic, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR27.76. Based on the TTM, the Book Value Change Per Share is INR9.87 per quarter. Based on the YOY, the Book Value Change Per Share is INR8.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gufic.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.120.0%0.120.0%0.050.0%0.070.0%0.050.0%0.030.0%
Usd Book Value Change Per Share0.120.0%0.120.0%0.090.0%0.070.0%0.050.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.120.0%0.120.0%0.090.0%0.070.0%0.050.0%0.040.0%
Usd Price Per Share2.94-2.94-1.35-1.61-1.40-0.95-
Price to Earnings Ratio25.18-25.18-25.05-23.41-29.67-31.52-
Price-to-Total Gains Ratio24.98-24.98-14.22-74.29-59.85-66.16-
Price to Book Ratio8.97-8.97-6.39-6.71-8.71-8.22-
Price-to-Total Gains Ratio24.98-24.98-14.22-74.29-59.85-66.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.45745
Number of shares224
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.120.05
Usd Total Gains Per Share0.120.05
Gains per Quarter (224 shares)26.3412.29
Gains per Year (224 shares)105.3649.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111049514939
2220920019788
333133052146137
444174102194186
555225153243235
666266204291284
777307254340333
888358305388382
999399355437431
1010104410406486480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Gufic Biosciences Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--9.8709.8700%8.003+23%6.026+64%4.593+115%3.084+220%
Book Value Per Share--27.76027.7600%17.890+55%18.513+50%14.435+92%9.724+185%
Current Ratio--1.7151.7150%1.592+8%1.494+15%1.381+24%1.260+36%
Debt To Asset Ratio--0.4840.4840%0.558-13%0.591-18%0.655-26%0.714-32%
Debt To Equity Ratio--0.9370.9370%1.261-26%1.638-43%2.204-57%2.890-68%
Dividend Per Share--0.0950.0950%0.037+154%0.061+56%0.056+68%0.053+78%
Enterprise Value--21871395539.00021871395539.0000%9025808493.000+142%10990724226.167+99%8717084135.700+151%5449314886.500+301%
Eps--9.8869.8860%4.563+117%5.602+76%4.348+127%2.769+257%
Ev To Sales Ratio--2.8072.8070%1.851+52%1.746+61%1.704+65%1.184+137%
Free Cash Flow Per Share--1.9381.9380%7.721-75%3.411-43%1.509+28%0.867+124%
Free Cash Flow To Equity Per Share--1.2941.2940%-0.389+130%0.400+224%0.270+379%0.182+609%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--73.190----------
Intrinsic Value_10Y_min--33.293----------
Intrinsic Value_1Y_max--4.267----------
Intrinsic Value_1Y_min--1.990----------
Intrinsic Value_3Y_max--15.157----------
Intrinsic Value_3Y_min--7.180----------
Intrinsic Value_5Y_max--28.867----------
Intrinsic Value_5Y_min--13.647----------
Market Cap29400282500.000+18%24129488539.00024129488539.0000%11080757493.000+118%13260393226.167+82%10825049735.700+123%7106217330.944+240%
Net Profit Margin--0.1230.1230%0.091+36%0.093+33%0.079+56%0.058+110%
Operating Margin----0%-0%0.047-100%0.084-100%0.082-100%
Operating Ratio--0.5670.5670%0.558+2%0.859-34%1.087-48%1.256-55%
Pb Ratio13.608+34%8.9668.9660%6.389+40%6.708+34%8.708+3%8.216+9%
Pe Ratio38.210+34%25.17725.1770%25.052+0%23.409+8%29.668-15%31.520-20%
Price Per Share377.750+34%248.900248.9000%114.300+118%136.783+82%118.930+109%80.107+211%
Price To Free Cash Flow Ratio194.931+34%128.441128.4410%14.804+768%75.069+71%17.113+651%-2.340+102%
Price To Total Gains Ratio37.909+34%24.97824.9780%14.216+76%74.290-66%59.854-58%66.159-62%
Quick Ratio--1.0321.0320%0.883+17%0.823+25%0.726+42%0.651+58%
Return On Assets--0.1840.1840%0.113+63%0.120+53%0.102+81%0.075+144%
Return On Equity--0.3560.3560%0.255+40%0.283+26%0.289+23%0.251+42%
Total Gains Per Share--9.9659.9650%8.040+24%6.087+64%4.649+114%3.138+218%
Usd Book Value--31755924.00031755924.0000%20465507.000+55%21177397.067+50%15762251.200+101%10322405.311+208%
Usd Book Value Change Per Share--0.1160.1160%0.094+23%0.071+64%0.054+115%0.036+220%
Usd Book Value Per Share--0.3280.3280%0.211+55%0.218+50%0.170+92%0.115+185%
Usd Dividend Per Share--0.0010.0010%0.000+154%0.001+56%0.001+68%0.001+78%
Usd Enterprise Value--258082467.360258082467.3600%106504540.217+142%129690545.869+99%102861592.801+151%64301915.661+301%
Usd Eps--0.1170.1170%0.054+117%0.066+76%0.051+127%0.033+257%
Usd Free Cash Flow--2216807.0002216807.0000%8832477.000-75%3902452.733-43%1847275.840+20%1052473.467+111%
Usd Free Cash Flow Per Share--0.0230.0230%0.091-75%0.040-43%0.018+28%0.010+124%
Usd Free Cash Flow To Equity Per Share--0.0150.0150%-0.005+130%0.005+224%0.003+379%0.002+609%
Usd Market Cap346923333.500+18%284727964.760284727964.7600%130752938.417+118%156472640.069+82%127735586.881+123%83853364.505+240%
Usd Price Per Share4.457+34%2.9372.9370%1.349+118%1.614+82%1.403+109%0.945+211%
Usd Profit--11309131.80011309131.8000%5219328.800+117%6408517.067+76%4751749.080+138%2964580.867+281%
Usd Revenue--91940360.80091940360.8000%57548446.600+60%63901153.600+44%53905114.000+71%39615146.178+132%
Usd Total Gains Per Share--0.1180.1180%0.095+24%0.072+64%0.055+114%0.037+218%
 EOD+4 -4MRQTTM+0 -0YOY+29 -83Y+29 -95Y+33 -510Y+33 -5

3.3 Fundamental Score

Let's check the fundamental score of Gufic Biosciences Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1538.210
Price to Book Ratio (EOD)Between0-113.608
Net Profit Margin (MRQ)Greater than00.123
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.032
Current Ratio (MRQ)Greater than11.715
Debt to Asset Ratio (MRQ)Less than10.484
Debt to Equity Ratio (MRQ)Less than10.937
Return on Equity (MRQ)Greater than0.150.356
Return on Assets (MRQ)Greater than0.050.184
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Gufic Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.445
Ma 20Greater thanMa 50356.295
Ma 50Greater thanMa 100347.443
Ma 100Greater thanMa 200392.623
OpenGreater thanClose363.600
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Gufic Biosciences Limited

Gufic Biosciences Limited engages in the manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anaesthetics, and immuno suppressants, as well as intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products. The company was founded in 1970 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2025-05-12 03:04:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Gufic earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Gufic to the Drugs - Generic industry mean.
  • A Net Profit Margin of 12.3% means that ₹0.12 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gufic Biosciences Limited:

  • The MRQ is 12.3%. The company is making a huge profit. +2
  • The TTM is 12.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.3%TTM12.3%0.0%
TTM12.3%YOY9.1%+3.2%
TTM12.3%5Y7.9%+4.4%
5Y7.9%10Y5.8%+2.0%
4.3.1.2. Return on Assets

Shows how efficient Gufic is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gufic to the Drugs - Generic industry mean.
  • 18.4% Return on Assets means that Gufic generated ₹0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gufic Biosciences Limited:

  • The MRQ is 18.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 18.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.4%TTM18.4%0.0%
TTM18.4%YOY11.3%+7.1%
TTM18.4%5Y10.2%+8.2%
5Y10.2%10Y7.5%+2.6%
4.3.1.3. Return on Equity

Shows how efficient Gufic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gufic to the Drugs - Generic industry mean.
  • 35.6% Return on Equity means Gufic generated ₹0.36 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gufic Biosciences Limited:

  • The MRQ is 35.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 35.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ35.6%TTM35.6%0.0%
TTM35.6%YOY25.5%+10.1%
TTM35.6%5Y28.9%+6.7%
5Y28.9%10Y25.1%+3.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Gufic Biosciences Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Gufic is operating .

  • Measures how much profit Gufic makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gufic to the Drugs - Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gufic Biosciences Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.4%-8.4%
5Y8.4%10Y8.2%+0.2%
4.3.2.2. Operating Ratio

Measures how efficient Gufic is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • An Operation Ratio of 0.57 means that the operating costs are ₹0.57 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.567. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.567. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.5670.000
TTM0.567YOY0.558+0.009
TTM0.5675Y1.087-0.520
5Y1.08710Y1.256-0.168
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Gufic Biosciences Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Gufic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drugs - Generic industry mean).
  • A Current Ratio of 1.72 means the company has ₹1.72 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 1.715. The company is able to pay all its short-term debts. +1
  • The TTM is 1.715. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.715TTM1.7150.000
TTM1.715YOY1.592+0.123
TTM1.7155Y1.381+0.335
5Y1.38110Y1.260+0.120
4.4.3.2. Quick Ratio

Measures if Gufic is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gufic to the Drugs - Generic industry mean.
  • A Quick Ratio of 1.03 means the company can pay off ₹1.03 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 1.032. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.032. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.032TTM1.0320.000
TTM1.032YOY0.883+0.148
TTM1.0325Y0.726+0.306
5Y0.72610Y0.651+0.074
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Gufic Biosciences Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Gufic assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gufic to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.48 means that Gufic assets are financed with 48.4% credit (debt) and the remaining percentage (100% - 48.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.484. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.484. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.484TTM0.4840.000
TTM0.484YOY0.558-0.074
TTM0.4845Y0.655-0.171
5Y0.65510Y0.714-0.059
4.5.4.2. Debt to Equity Ratio

Measures if Gufic is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gufic to the Drugs - Generic industry mean.
  • A Debt to Equity ratio of 93.7% means that company has ₹0.94 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.937. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.937. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.937TTM0.9370.000
TTM0.937YOY1.261-0.323
TTM0.9375Y2.204-1.267
5Y2.20410Y2.890-0.686
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Gufic generates.

  • Above 15 is considered overpriced but always compare Gufic to the Drugs - Generic industry mean.
  • A PE ratio of 25.18 means the investor is paying ₹25.18 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gufic Biosciences Limited:

  • The EOD is 38.210. Based on the earnings, the company is overpriced. -1
  • The MRQ is 25.177. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.177. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD38.210MRQ25.177+13.033
MRQ25.177TTM25.1770.000
TTM25.177YOY25.052+0.125
TTM25.1775Y29.668-4.491
5Y29.66810Y31.520-1.852
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gufic Biosciences Limited:

  • The EOD is 194.931. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 128.441. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 128.441. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD194.931MRQ128.441+66.491
MRQ128.441TTM128.4410.000
TTM128.441YOY14.804+113.637
TTM128.4415Y17.113+111.327
5Y17.11310Y-2.340+19.454
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Gufic is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • A PB ratio of 8.97 means the investor is paying ₹8.97 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Gufic Biosciences Limited:

  • The EOD is 13.608. Based on the equity, the company is expensive. -2
  • The MRQ is 8.966. Based on the equity, the company is overpriced. -1
  • The TTM is 8.966. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.608MRQ8.966+4.642
MRQ8.966TTM8.9660.000
TTM8.966YOY6.389+2.577
TTM8.9665Y8.708+0.258
5Y8.70810Y8.216+0.492
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets5,214,017
Total Liabilities2,522,837
Total Stockholder Equity2,691,180
 As reported
Total Liabilities 2,522,837
Total Stockholder Equity+ 2,691,180
Total Assets = 5,214,017

Assets

Total Assets5,214,017
Total Current Assets3,207,540
Long-term Assets0
Total Current Assets
Short-term Investments 148,664
Net Receivables 1,515,529
Inventory 1,155,669
Other Current Assets 1,008
Total Current Assets  (as reported)3,207,540
Total Current Assets  (calculated)2,820,870
+/- 386,670
Long-term Assets
Property Plant Equipment 1,554,310
Intangible Assets 6,102
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,560,412
+/- 1,560,412

Liabilities & Shareholders' Equity

Total Current Liabilities1,869,822
Long-term Liabilities0
Total Stockholder Equity2,691,180
Total Current Liabilities
Short-term Debt 65,992
Total Current Liabilities  (as reported)1,869,822
Total Current Liabilities  (calculated)65,992
+/- 1,803,830
Long-term Liabilities
Long term Debt Total 477,261
Capital Lease Obligations Min Short Term Debt-65,992
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)411,269
+/- 411,269
Total Stockholder Equity
Common Stock96,945
Retained Earnings 2,594,235
Total Stockholder Equity (as reported)2,691,180
Total Stockholder Equity (calculated)2,691,180
+/-0
Other
Cash And Equivalents116,080
Cash and Short Term Investments 264,744
Common Stock Shares Outstanding 96,945
Liabilities and Stockholders Equity 5,214,017
Net Working Capital 1,337,718



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
1,111,458
1,272,879
1,515,982
1,784,631
2,380,322
2,795,397
3,562,407
3,920,610
5,214,017
5,214,0173,920,6103,562,4072,795,3972,380,3221,784,6311,515,9821,272,8791,111,458
   > Total Current Assets 
693,044
914,790
1,189,724
1,432,465
1,982,045
2,325,135
2,634,806
2,605,828
3,207,540
3,207,5402,605,8282,634,8062,325,1351,982,0451,432,4651,189,724914,790693,044
       Cash And Cash Equivalents 
25,415
62,065
42,824
28,727
36,712
36,614
41,839
62,014
0
062,01441,83936,61436,71228,72742,82462,06525,415
       Short-term Investments 
0
0
0
0
37,154
38,901
120,860
69,282
148,664
148,66469,282120,86038,90137,1540000
       Net Receivables 
395,108
473,061
556,895
521,213
808,004
1,031,804
1,012,394
1,245,007
1,515,529
1,515,5291,245,0071,012,3941,031,804808,004521,213556,895473,061395,108
       Inventory 
261,154
368,014
502,631
630,163
942,010
942,846
1,091,977
944,046
1,155,669
1,155,669944,0461,091,977942,846942,010630,163502,631368,014261,154
       Other Current Assets 
10,214
9,484
67,793
224,413
501
6,088
29,681
1,559
1,008
1,0081,55929,6816,088501224,41367,7939,48410,214
   > Long-term Assets 
0
0
0
336,579
390,374
470,262
927,601
0
0
00927,601470,262390,374336,579000
       Property Plant Equipment 
301,862
250,751
221,254
219,901
244,355
337,080
716,963
1,129,253
1,554,310
1,554,3101,129,253716,963337,080244,355219,901221,254250,751301,862
       Goodwill 
0
0
0
0
280
224
210
0
0
002102242800000
       Long Term Investments 
93
93
93
93
0
0
0
0
0
0000093939393
       Intangible Assets 
425
319
213
108
4,373
3,440
5,360
4,451
6,102
6,1024,4515,3603,4404,373108213319425
       Long-term Assets Other 
0
0
0
33,312
16,530
378
377
0
0
0037737816,53033,312000
> Total Liabilities 
849,371
1,001,879
1,228,241
1,411,358
1,838,965
2,041,918
2,603,868
2,186,245
2,522,837
2,522,8372,186,2452,603,8682,041,9181,838,9651,411,3581,228,2411,001,879849,371
   > Total Current Liabilities 
603,103
836,095
1,103,117
1,281,771
1,685,493
1,863,433
2,245,672
1,636,624
1,869,822
1,869,8221,636,6242,245,6721,863,4331,685,4931,281,7711,103,117836,095603,103
       Short-term Debt 
334,040
328,187
322,820
469,672
691,679
846,900
894,327
163,243
65,992
65,992163,243894,327846,900691,679469,672322,820328,187334,040
       Short Long Term Debt 
334,040
328,187
427,572
568,065
713,054
864,363
928,069
0
0
00928,069864,363713,054568,065427,572328,187334,040
       Accounts payable 
317,963
495,333
526,224
397,371
759,794
778,051
1,086,228
0
0
001,086,228778,051759,794397,371526,224495,333317,963
       Other Current Liabilities 
57,210
68,628
84,409
139,966
72,456
95,566
95,019
0
0
0095,01995,56672,456139,96684,40968,62857,210
   > Long-term Liabilities 
0
0
0
176,385
153,009
178,485
358,195
0
0
00358,195178,485153,009176,385000
       Long term Debt Total 
0
0
74,579
66,232
83,192
113,117
179,235
382,489
477,261
477,261382,489179,235113,11783,19266,23274,57900
       Capital Lease Obligations 
0
0
0
1,705
1,078
379
96,329
0
0
0096,3293791,0781,705000
       Long-term Liabilities Other 
0
0
0
80,493
0
1
-2
0
0
00-21080,493000
> Total Stockholder Equity
262,087
271,000
287,741
373,273
541,357
753,479
958,539
1,734,365
2,691,180
2,691,1801,734,365958,539753,479541,357373,273287,741271,000262,087
   Common Stock
77,350
77,350
77,350
77,350
77,830
77,830
77,830
96,945
96,945
96,94596,94577,83077,83077,83077,35077,35077,35077,350
   Retained Earnings 
183,487
192,400
210,391
295,923
463,527
675,649
880,709
1,637,420
2,594,235
2,594,2351,637,420880,709675,649463,527295,923210,391192,400183,487
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
1,250
1,250
1,250
1,250
1,250
714
-19,083
0
0
00-19,0837141,2501,2501,2501,2501,250



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,906,208
Cost of Revenue-3,642,668
Gross Profit3,263,5403,263,540
 
Operating Income (+$)
Gross Profit3,263,540
Operating Expense--
Operating Income1,153,3093,263,540
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,789,874
Selling And Marketing Expenses-
Operating Expense-1,789,874
 
Net Interest Income (+$)
Interest Income81,838
Interest Expense--
Other Finance Cost-81,838
Net Interest Income-
 
Pretax Income (+$)
Operating Income1,153,309
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,067,2091,153,309
EBIT - interestExpense = 0
797,048
797,048
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-1,067,209
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,067,209
Tax Provision-270,161
Net Income From Continuing Ops-797,048
Net Income797,048
Net Income Applicable To Common Shares797,048
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Gufic
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gufic. The general trend of Gufic is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gufic's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Gufic Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gufic Biosciences Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 405.90 < 409.90 < 459.55.

The bearish price targets are: 294.98 > 289.08 > 285.00.

Know someone who trades $509079? Share this with them.👇

Gufic Biosciences Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gufic Biosciences Limited. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gufic Biosciences Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gufic Biosciences Limited. The current macd is 4.54550859.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gufic price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Gufic. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Gufic price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Gufic Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) ChartGufic Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gufic Biosciences Limited. The current adx is 20.54.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Gufic shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Gufic Biosciences Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gufic Biosciences Limited. The current sar is 329.79.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Gufic Biosciences Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gufic Biosciences Limited. The current rsi is 58.45. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Gufic Biosciences Limited Daily Relative Strength Index (RSI) ChartGufic Biosciences Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gufic Biosciences Limited. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gufic price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Gufic Biosciences Limited Daily Stochastic Oscillator ChartGufic Biosciences Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gufic Biosciences Limited. The current cci is 82.85.

Gufic Biosciences Limited Daily Commodity Channel Index (CCI) ChartGufic Biosciences Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gufic Biosciences Limited. The current cmo is 23.48.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Gufic Biosciences Limited Daily Chande Momentum Oscillator (CMO) ChartGufic Biosciences Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gufic Biosciences Limited. The current willr is -44.05320814.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Gufic is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Gufic Biosciences Limited Daily Williams %R ChartGufic Biosciences Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gufic Biosciences Limited.

Gufic Biosciences Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gufic Biosciences Limited. The current atr is 18.61.

Gufic Biosciences Limited Daily Average True Range (ATR) ChartGufic Biosciences Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gufic Biosciences Limited. The current obv is 1,063,185.

Gufic Biosciences Limited Daily On-Balance Volume (OBV) ChartGufic Biosciences Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gufic Biosciences Limited. The current mfi is 55.46.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Gufic Biosciences Limited Daily Money Flow Index (MFI) ChartGufic Biosciences Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gufic Biosciences Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-31MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Gufic Biosciences Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gufic Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.445
Ma 20Greater thanMa 50356.295
Ma 50Greater thanMa 100347.443
Ma 100Greater thanMa 200392.623
OpenGreater thanClose363.600
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Gufic with someone you think should read this too:
  • Are you bullish or bearish on Gufic? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gufic? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gufic Biosciences Limited

I send you an email if I find something interesting about Gufic Biosciences Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Gufic Biosciences Limited.

Receive notifications about Gufic Biosciences Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.